December 11, 2024
Global Chronic Disease Management Market Size to Reach USD 17.28 Billion by 2033

The global chronic disease management market size is estimated to be worth USD 5.57 billion in 2024 and is projected to reach from USD 6.87 billion in 2025 to USD 17.28 billion by 2033, growing at a CAGR of 12.80% during the forecast period (2025-2033).

New York, United States, Sept. 30, 2024 (GLOBE NEWSWIRE) — Chronic disease management denotes the systematic strategy employed to oversee, address, and enhance the quality of life for those with enduring health concerns, including cardiovascular illnesses, respiratory disorders, and arthritis. The approach encompasses preventative care, tailored treatment regimens, consistent monitoring, and patient education to mitigate disease development, limit consequences, and decrease healthcare expenditures. This method frequently integrates digital health technologies such as telemedicine, remote monitoring, and mobile health applications to improve patient participation and provide ongoing care.

The increasing incidence of chronic ailments, including cardiovascular diseases, respiratory disorders, and arthritis, is a primary catalyst for expansion in the chronic disease management industry. These disorders necessitate continuous care, consistent monitoring, and tailored management strategies to avert complications and enhance patient outcomes. With the rising prevalence of chronic diseases, healthcare professionals are adopting innovative technologies like remote monitoring, telemedicine, and digital health platforms to improve the management of these ailments. The ongoing requirement for care generates a persistent desire for creative solutions that can augment patient participation, deliver real-time data, and facilitate proactive treatments, thereby enhancing the overall management of chronic diseases.

Download Free Sample Report PDF @ 

Market Dynamics

Rising Prevalence of Chronic Diseases Drives the Global Market

The increasing incidence of chronic diseases significantly influences the worldwide chronic disease management market. With the rising prevalence of illnesses such as diabetes, cardiovascular disease, and chronic respiratory disorders, there is a growing need for appropriate management options. The expanding patient demographic requires sophisticated tools and programs for illness management and monitoring, resulting in increased utilization of digital health technologies, integrated care models, and preventive efforts.

  • For instance, the America’s Health Rankings 2023 Annual Report indicated that diabetes affects 11.5% of people, impacting around 31.9 million Americans. Furthermore, chronic ailments such as Chronic Obstructive Pulmonary Disease (COPD) and cancer exhibited notable disparities across various ethnic groups, with American Indian/Alaska Native adults experiencing COPD at rates 7.1 times greater than Asian adults and American adults having cancer rates 3.9 times higher than those of Asian adults.

link

Leave a Reply

Your email address will not be published. Required fields are marked *